Exelon, Rivastigmine News

"Is there any advantage of giving patients higher doses of rivastigmine? There doesn't seem to be any," said lead review author Jacqueline Birks, senior medical statistician for the University of Oxford, in England.

Sometimes less is better than more. In a new study, lower doses of an Alzheimer's drug delivered via skin patches improve cognition with fewer serious side effects than higher doses.

Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in relevant parts of the brain by the use of cholinesterase inhibitors to delay the breakdown of acetylcholine released ...

LONDON, March 19, 2009-On 19 March the Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Nimvastid 1.5 mg, 3 mg, 4.5 mg, 6 mg hard capsules and Nimvastid 1.5 mg, 3 mg, 4.5 mg, 6 mg Orodispersible tablets intended for the symptomatic treatment ...

METHODS: Sixteen electronic databases and bibliographies of related papers were searched for published/unpublished English language studies, and experts and pharmaceutical companies were consulted for ...